Maze Therapeutics, Inc. Common Stock MAZE

$28.38 +26.75% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 Insider transaction 2026-09-08 View →
4 Insider transaction 2026-09-04 View →
4 Insider transaction 2026-09-04 View →
4 Insider transaction 2026-09-04 View →
4 Insider transaction 2026-09-04 View →
4 Insider transaction 2026-09-03 View →
4 Insider transaction 2026-09-03 View →
4 Insider transaction 2026-09-03 View →
4 Insider transaction 2026-09-03 View →
4 Insider transaction 2026-08-31 View →
4 Insider transaction 2026-08-17 View →
4 Insider transaction 2026-08-17 View →
8-K 8-K 2026-08-17 View →
4 Insider transaction 2026-08-14 View →
10-Q 10-Q 2026-08-11 View →
8-K 8-K 2026-08-11 View →
4 Insider transaction 2026-08-05 View →
4 Insider transaction 2026-07-31 View →
4 Insider transaction 2026-07-02 View →
4 Insider transaction 2026-07-02 View →
4 Insider transaction 2026-07-01 View →
4 Insider transaction 2026-06-24 View →
4 Insider transaction 2026-06-10 View →
4 Insider transaction 2026-06-10 View →
4 Insider transaction 2026-06-10 View →
4 Insider transaction 2026-06-10 View →
4 Insider transaction 2026-06-10 View →
4 Insider transaction 2026-06-10 View →
8-K 8-K 2026-06-10 View →
4 Insider transaction 2026-06-03 View →
4 Insider transaction 2026-06-03 View →
4 Insider transaction 2026-06-02 View →
4 Insider transaction 2026-05-27 View →
8-K 8-K 2026-05-22 View →
4 Insider transaction 2026-05-18 View →
4 Insider transaction 2026-05-18 View →
10-Q 10-Q 2026-05-12 View →
8-K 8-K 2026-05-12 View →
4 Insider transaction 2026-05-06 View →
4 Insider transaction 2026-05-06 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$28.38
Market Cap
$1.24 billion
52-Week Range
$12.81 $53.65
Average Volume
581K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.